RT Book, Section A1 Papadakis, Maxine A. A1 McPhee, Stephen J. A1 Rabow, Michael W. A1 McQuaid, Kenneth R. SR Print(0) ID 1183884708 T1 Diabetes Mellitus & Hypoglycemia T2 Current Medical Diagnosis & Treatment 2022 YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781264269389 LK accessmedicine.mhmedical.com/content.aspx?aid=1183884708 RD 2024/03/28 AB Dapagliflozin reduced the risk of end-stage kidney disease or death from renal and cardiovascular causes in a 2020 multinational study of 4304 patients with chronic kidney disease.